Profarma Distribuidora De Stock Probability Of Bankruptcy
| PFRM3 Stock | BRL 6.11 0.20 3.38% |
Profarma |
Profarma Distribuidora de Company probability of financial unrest Analysis
Profarma Distribuidora's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Profarma Distribuidora Probability Of Bankruptcy | Less than 9% |
Most of Profarma Distribuidora's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profarma Distribuidora de is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Profarma Distribuidora probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Profarma Distribuidora odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Profarma Distribuidora de financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Profarma Distribuidora de has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Health Care Providers & Services sector and 58.6% lower than that of the Health Care industry. The probability of bankruptcy for all Brazil stocks is 77.4% higher than that of the company.
Profarma Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profarma Distribuidora's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profarma Distribuidora could also be used in its relative valuation, which is a method of valuing Profarma Distribuidora by comparing valuation metrics of similar companies.Profarma Distribuidora is currently under evaluation in probability of bankruptcy category among related companies.
Profarma Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Shares Owned By Insiders | 66.17 % | |||
| Shares Owned By Institutions | 26.52 % | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 6.41 B | |||
| Gross Profit | 907.57 M | |||
| EBITDA | 225.52 M | |||
| Net Income | 78.19 M | |||
| Cash And Equivalents | 139.49 M | |||
| Cash Per Share | 1.86 X | |||
| Total Debt | 740.04 M | |||
| Debt To Equity | 91.40 % | |||
| Current Ratio | 1.27 X | |||
| Book Value Per Share | 8.86 X | |||
| Cash Flow From Operations | 107.58 M | |||
| Earnings Per Share | 0.71 X | |||
| Target Price | 7.5 | |||
| Number Of Employees | 7.08 K | |||
| Beta | 1.14 | |||
| Market Capitalization | 399.71 M | |||
| Total Asset | 4.03 B | |||
| Retained Earnings | 92 M | |||
| Working Capital | 615 M | |||
| Current Asset | 1.57 B | |||
| Current Liabilities | 951 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 1.29 % | |||
| Net Asset | 4.03 B | |||
| Last Dividend Paid | 0.27 |
About Profarma Distribuidora Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profarma Distribuidora de's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profarma Distribuidora using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profarma Distribuidora de based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Profarma Distribuidora in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Profarma Distribuidora's short interest history, or implied volatility extrapolated from Profarma Distribuidora options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |